CSIMarket Company Name, Ticker, Suppliers, else..
 
Therapeuticsmd Inc   (NASDAQ: TXMD)
 
Price: $2.2100 $-0.03 -1.339%
Day's High: $2.2300000190734863 Week Perf: 1.38 %
Day's Low: $ 2.18 30 Day Perf: 5.74 %
Volume (M): 7,785 52 Wk High: $ 2.95
Volume (M$): $ 0 52 Wk Avg: $1.89
Open: $2.23 52 Wk Low: $0.99



 Market Capitalization (Millions $) 26
 Shares Outstanding (Millions) 12
 Employees 1
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Business Description


TherapeuticsMD Inc is a pharmaceutical company based in Boca Raton, Florida. The company focuses on developing and commercializing innovative products for women's health. Their mission is to improve the lives of women at all stages through life with high-quality, innovative and effective products.

TherapeuticsMD is known for their prescription hormone therapy products such as BIJUVA, which is a combination of estradiol and progesterone designed to treat moderate to severe vasomotor symptoms of menopause. It is the first and only FDA-approved hormone therapy that combines bio-identical estradiol and progesterone in a single, oral capsule dose.

Another hormone therapy product from TherapeuticsMD is IMVEXXY, which is an ultra-low dose vaginal estradiol product designed to help women with moderate to severe painful sex due to menopause. The company also offers a line of vitamins and supplements to support women's health.

In addition to their hormone therapy products, TherapeuticsMD also has a research and development team that is dedicated to discovering and developing new products aimed at treating different women's health conditions. Their team of experts is constantly working on ways to improve women's health through innovative and effective products.

TherapeuticsMD Inc has also made notable progress in their commitment to sustainability, as shown through their recently released Sustainability Report. The report highlights their initiatives in resource reduction, environmental stewardship, and social responsibility.

Overall, TherapeuticsMD Inc is a company that is dedicated to improving women's health through innovative and effective products. With a strong focus on research and development, the company is poised to continue growing and expanding their product offerings in the women's health space.


   Company Address: 951 Yamato Road, Boca Raton 33431 FL
   Company Phone Number: 961-1900   Stock Exchange / Ticker: NASDAQ TXMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
JNJ        2.68% 
MRK        1.33% 
PFE        1.75% 
TEVA   -0.22%    
VRTX        0.82% 
VTRS        3.3% 
• View Complete Report
   



Business Update

An In-depth Review of TherapeuticsMD's Financial Performance in Q1 2024: A Comparative Analysis with Competitors

Published Mon, May 13 2024 5:29 AM UTC

TherapeuticsMD, Inc., a company that notably owns the rights to pharmaceutical royalties (NASDAQ: TXMD), has recently announced their first quarter financial results for the fiscal year 2024. As a respected journal in the field of scientific inquiry and pharmaceutical advancements, we deem it crucial to conduct an extensive review of this eminently influential industry playe...
Business Update

TherapeuticsMD Faces Financial Challenges and Net Loss in First Quarter 2024: A Closer Look at the Pharmaceutical Royalties Company's Performance

Published Sun, May 12 2024 4:45 AM UTC

TherapeuticsMD Reports First Quarter 2024 Financial Results with Net Loss from Continuing OperationsTherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD) recently released its financial results for the first quarter ending March 31, 2024. The company reported a net loss from continuing operations of $0.8 million, or $0.07 per basic and diluted common share, com...
Business Update

TherapeuticsMD Inc. Skyrockets in Q1 2024, Cementing Its Position as a Leading Pharmaceutical Royalty Holder

Published Sat, May 11 2024 4:24 AM UTC

TherapeuticsMD Inc. Reports Steady Financial Growth in the First Quarter of 2024In an impressive display of financial stability, TherapeuticsMD Inc. (NASDAQ: TXMD) has announced its first quarter 2024 financial results, showcasing a substantial improvement compared to the previous year. As a leading company that holds rights to pharmaceutical royalties, TherapeuticsMD exhibi...
Business Update

TherapeuticsMD in Q1 2024: Navigating Financial Crossroads Amid Competitive Healthcare Market

Published Fri, May 10 2024 8:47 PM UTC

As the first quarter of 2024 concludes, TherapeuticsMD, Inc. (NASDAQ: TXMD), a healthcare-focused company specialising in securing royalties for pharmaceutical products, has made considerable strides towards achieving its financial goals. However, an insightful look into the specifics reveals a mix of wins and losses, suggesting that the journey ahead may still have a few hu...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 7.87
Price to Sales (Expected) -
Price to Book 0.95
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.84
Working Capital Ratio 3.22
Leverage Ratio (MRQ) 0.38
Total Debt to Equity -
Interest Coverage (TTM) 34
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.02 $
Revenues (TTM) 0.28 $
Cash Flow (TTM) 0.2 $
Cash 0.79 $
Book Value 2.33 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 3,270,000
Net Income per Employee (TTM) -217,000
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.09

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -93.9 %
Net Margin (MRQ) 17.84 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Therapeuticsmd Inc's Segments
All Other Segments    183.31 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.